Trading Signals: HALO Stock Price Prediction and Forecast (Mon. Aug. 10, 2015 - Wed. Sep. 27, 2023)(Halozyme Therapeutics Inc)
| HALO latest price $44.4700 (-2.54%) ($44.4700 - $44.4700) on Mon. Jun. 6, 2022. | |
| | Trend Analysis and Forecast | | | Average Daily Percentage Swing | 2.27% (three month average) | RSI | 64 | Latest Price | $44.4700(-2.54%) | Stocks Behave Similarly | Similar Stock List | Daily Trend | HALO declines -1.6% a day on average for past five trading days. | Weekly Trend | HALO advances 2.1% a week on average for past two weeks. | Market Behavior | Normal for large cap. Value stock rally for small cap. | Correlated ETFs | Broad market will support HALO advance at 0% a week (0% probability) IBB(47%) IWO(41%) IWM(40%) IWC(39%) IWN(39%) | Factors Impacting HALO price | HALO will decline at least -1.135% in a week (0% probabilities). VIXM(-19%) UUP(-8%) VXX(-7%) TBT(-4%) GLD(2%) | | | | | Relative Volatility | (options are extremely cheap) | | | Market Trend Strength | -1.135% (StdDev 2.27%) | Hourly BBV | -2.3 () | Intraday Trend | 0% | | | |
|
5 Day Moving Average | $45.47(-2.2%) | 10 Day Moving Average | $45.76(-2.82%) | 20 Day Moving Average | $43.56(2.09%) | To recent high | -7.9% | To recent low | 29.8% | Market Cap | $6.078b | | | | Halozyme Therapeutics, Inc. is a biopharmaceutical company, which engages in research, development & commercialization of human enzymes and drug candidates. It focuses on novel oncology therapies that target the tumor microenvironment. Its products include PEGPH20, HTI-1511, PEG-ADA2, and HYLENEX recombinant. The company was founded by Gregory Ian Frost on February 26, 1998 and is headquartered in San Diego, CA. |